Florida 2024 2024 Regular Session

Florida House Bill H0115 Introduced / Bill

Filed 10/09/2023

                       
 
HB 115  	2024 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb0115-00 
Page 1 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
A bill to be entitled 1 
An act relating to a progressive supranuclear palsy 2 
and other neurodegenerative diseases policy workgroup; 3 
providing a short title; creating s. 408.0622, F.S.; 4 
requiring the Secretary of Health Care Administration, 5 
in conjunction with the State Surgeon General, to 6 
establish a progressive supranuclear palsy and other 7 
neurodegenerative diseases policy workgroup; providing 8 
for duties, membership, and meetings of the workgroup; 9 
requiring the secretary to submit annual reports and a 10 
final report by a specified date to the Governor and 11 
the Legislature; providing an effective date. 12 
 13 
Be It Enacted by the Legislature of the State of Florida: 14 
 15 
 Section 1.  This act may be cited as the "Justo R. Cortes 16 
Progressive Supranuclear Palsy Act." 17 
 Section 2.  Section 408.0622, Florida Statutes, is created 18 
to read: 19 
 408.0622  Progressive supranuclear palsy and other 20 
neurodegenerative diseases policy workgroup. — 21 
 (1)  The Secretary of Health Care Administration, in 22 
conjunction with the State Surgeon General, shall establish a 23 
progressive supranuclear palsy and other neurodegenerative 24 
diseases policy workgroup. 25     
 
HB 115  	2024 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb0115-00 
Page 2 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
 (2)  The workgroup shall: 26 
 (a)  Identify the aggregate number of peo ple in the state 27 
diagnosed with progressive supranuclear palsy and other 28 
neurodegenerative diseases annually. 29 
 (b)  Identify how data is collected regarding diagnoses of 30 
progressive supranuclear palsy and other neurodegenerative 31 
diseases and adverse health outcomes associated with such 32 
conditions. 33 
 (c)  Identify how progressive supranuclear palsy and other 34 
neurodegenerative diseases impact the lives of people in the 35 
state. 36 
 (d)  Identify the standard of care for the surveillance, 37 
detection, and treatment of progressive supranuclear palsy and 38 
other neurodegenerative diseases. 39 
 (e)  Identify emerging treatments, therapies, and research 40 
relating to progressive supranuclear palsy and other 41 
neurodegenerative diseases. 42 
 (f)  Develop a risk surveillance system to h elp health care 43 
providers identify patients who may be at a higher risk of 44 
developing progressive supranuclear palsy and other 45 
neurodegenerative diseases. 46 
 (g)  Develop policy recommendations to help improve patient 47 
awareness of progressive supranuclear pa lsy and other 48 
neurodegenerative diseases. 49 
 (h)  Develop policy recommendations to help improve 50     
 
HB 115  	2024 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb0115-00 
Page 3 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
surveillance and detection of patients who may be at a higher 51 
risk of being diagnosed with progressive supranuclear palsy and 52 
other neurodegenerative diseases in licensed health care 53 
facilities, including hospitals, nursing homes, assisted living 54 
facilities, residential treatment facilities, and ambulatory 55 
surgical centers. 56 
 (i)  Develop policy recommendations relating to guideli nes 57 
that affect the standard of care for patients with progressive 58 
supranuclear palsy and other neurodegenerative diseases. 59 
 (j)  Develop policy recommendations relating to providing 60 
patients and their families with written notice of increased 61 
risks of being diagnosed with progressive supranuclear palsy and 62 
other neurodegenerative diseases. 63 
 (3)(a)  The workgroup shall be composed of health care 64 
providers, family members or caretakers of patients who have 65 
been diagnosed with progressive supranuclear palsy a nd other 66 
neurodegenerative diseases, advocates, and other interested 67 
parties and associations. 68 
 (b)  The President of the Senate and the Speaker of the 69 
House of Representatives shall each appoint two members to the 70 
workgroup. 71 
 (c)  Members of the workgroup shall serve without 72 
compensation. 73 
 (d)  The State Surgeon General shall appoint the chair of 74 
the workgroup. 75     
 
HB 115  	2024 
 
 
 
CODING: Words stricken are deletions; words underlined are additions. 
hb0115-00 
Page 4 of 4 
F L O R I D A H O U S E O F R E P	R E S E N T A T I V E	S 
 
 
 
 (e)  The chair of the workgroup may create subcommittees to 76 
help conduct research, schedule speakers on important subjects, 77 
and draft reports and policy recommendations. 78 
 (f)  Meetings of the workgroup may be held through 79 
teleconference or other electronic means. 80 
 (4)(a)  The Secretary of Health Care Administration shall 81 
submit an annual report detailing his or her findings and 82 
providing recommendat ions to the Governor, the President of the 83 
Senate, and the Speaker of the House of Representatives. 84 
 (b)  The Secretary of Health Care Administration shall 85 
submit a final report detailing his or her findings and 86 
providing recommendations to the Governor, t he President of the 87 
Senate, and the Speaker of the House of Representatives by 88 
January 4, 2026. 89 
 Section 3.  This act shall take effect July 1, 2024. 90